Načítá se...
Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies
Rhabdomyosarcoma (RMS) represents a rare, heterogeneous group of mesodermal malignancies with skeletal muscle differentiation. One major subgroup of RMS tumors (so-called “fusion-positive” tumors) carries exclusive chromosomal translocations that join the DNA-binding domain of the PAX3 or PAX7 gene...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Cold Spring Harbor Laboratory Press
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4208704/ https://ncbi.nlm.nih.gov/pubmed/25368019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a025650 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|